For the more than 48 million Americans with substance use disorders, including a disproportionate share of veterans, GLP-1 drugs are not yet an approved addiction treatment. But the evidence base is ...
Vans Warped Tour announced full lineup for the Aug. 21-22 stop in Montreal, which will feature Atreyu, Yellowcard, Sublime, ...
As FiercePharma explains, the company is attempting to rebrand itself in the wake of a Justice Department investigation, a class-action lawsuit, and a failed attempt at treating Alzheimer’s. Plus: The ...
An Ohio campaign is making a final push for signatures to put a referendum on the November ballot that would repeal a law rolling back the state’s marijuana law and ban the sale of consumable hemp ...
Financial support to prepare the submission of the Phase 2 clinical trial application for NFL-102 expected in mid-2026 Strengthening ...
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, ...
First Cochlear Implant Company to Announce Completed Enrollment of a U.S. Pivotal Clinical Trial for a Fully Implanted Cochlear Implant seeking FDA ApprovalWhite Bear Lake, Minnesota--(Newsfile Corp.
Logan Graham, the leader of the red team, recalled the bioweapons scare as an example of the challenges Anthropic faces at a pivotal moment for the company and the world. Anthropic is the frontier AI ...
This week we take a look back at 1991, when Hannibal Lecter (a.k.a Anthony Hopkins) uttered the terrifying phrase: “Hello Clarice. A census taker once tried to test me. I ate his liver with some fava ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as ...
In her new book The Calling, she describes the experiences and lessons of her year spent as a secular priest. Full disclosure: I was only asked to review this book because I said some nice things ...
New! Sign up for our free email newsletter.